420 related articles for article (PubMed ID: 28182801)
1. Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.
Rutter WC; Burgess DR; Talbert JC; Burgess DS
J Hosp Med; 2017 Feb; 12(2):77-82. PubMed ID: 28182801
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
[TBL] [Abstract][Full Text] [Related]
3. Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
Rutter WC; Burgess DS
Pharmacotherapy; 2017 May; 37(5):593-598. PubMed ID: 28247443
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
[TBL] [Abstract][Full Text] [Related]
6. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
Liu K; Zhang Y; Xu X; Wu B; Ni J; Li T; Xing C; Mao H
Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
[TBL] [Abstract][Full Text] [Related]
7. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
8. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
[TBL] [Abstract][Full Text] [Related]
9. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS
Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
Karino S; Kaye KS; Navalkele B; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Pogue JM
Antimicrob Agents Chemother; 2016 Jun; 60(6):3743-50. PubMed ID: 27067325
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
Komerdelj IA; Buckley MS; D'Alessio PA; Ziadat DS; Kobic E; Rangan P; Agarwal SK; Tinta NC; Yerondopoulos MJ; Kane-Gill SL
J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
[No Abstract] [Full Text] [Related]
13. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
Carreno J; Smiraglia T; Hunter C; Tobin E; Lomaestro B
Int J Antimicrob Agents; 2018 Nov; 52(5):643-650. PubMed ID: 30103003
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Balcı C; Uzun Ö; Arıcı M; Hayran SA; Yüce D; Ünal S
Int J Antimicrob Agents; 2018 Aug; 52(2):180-184. PubMed ID: 29649586
[TBL] [Abstract][Full Text] [Related]
15. Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.
Cotner SE; Rutter WC; Burgess DR; Wallace KL; Martin CA; Burgess DS
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760891
[TBL] [Abstract][Full Text] [Related]
16. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
Gomes DM; Smotherman C; Birch A; Dupree L; Della Vecchia BJ; Kraemer DF; Jankowski CA
Pharmacotherapy; 2014 Jul; 34(7):662-9. PubMed ID: 24753221
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
[TBL] [Abstract][Full Text] [Related]
18. Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam.
Abouelkheir M; Alsubaie S
Pediatr Int; 2018 Feb; 60(2):136-141. PubMed ID: 29181890
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
LeCleir LK; Pettit RS
Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Rutter WC; Burgess DS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]